1. Home
  2. NUWE vs NEA Comparison

NUWE vs NEA Comparison

Compare NUWE & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • NEA
  • Stock Information
  • Founded
  • NUWE 1999
  • NEA 2002
  • Country
  • NUWE United States
  • NEA United States
  • Employees
  • NUWE 38
  • NEA N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NEA Finance/Investors Services
  • Sector
  • NUWE Health Care
  • NEA Finance
  • Exchange
  • NUWE Nasdaq
  • NEA Nasdaq
  • Market Cap
  • NUWE 3.9M
  • NEA N/A
  • IPO Year
  • NUWE N/A
  • NEA N/A
  • Fundamental
  • Price
  • NUWE $0.93
  • NEA $10.70
  • Analyst Decision
  • NUWE Strong Buy
  • NEA
  • Analyst Count
  • NUWE 1
  • NEA 0
  • Target Price
  • NUWE $17.00
  • NEA N/A
  • AVG Volume (30 Days)
  • NUWE 74.6K
  • NEA 803.4K
  • Earning Date
  • NUWE 05-06-2025
  • NEA 01-01-0001
  • Dividend Yield
  • NUWE N/A
  • NEA 4.23%
  • EPS Growth
  • NUWE N/A
  • NEA N/A
  • EPS
  • NUWE N/A
  • NEA N/A
  • Revenue
  • NUWE $8,740,000.00
  • NEA N/A
  • Revenue This Year
  • NUWE $22.96
  • NEA N/A
  • Revenue Next Year
  • NUWE $29.97
  • NEA N/A
  • P/E Ratio
  • NUWE N/A
  • NEA N/A
  • Revenue Growth
  • NUWE N/A
  • NEA N/A
  • 52 Week Low
  • NUWE $0.75
  • NEA $9.20
  • 52 Week High
  • NUWE $14.00
  • NEA $11.37
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 44.77
  • NEA 39.11
  • Support Level
  • NUWE $0.87
  • NEA $10.62
  • Resistance Level
  • NUWE $0.95
  • NEA $10.76
  • Average True Range (ATR)
  • NUWE 0.08
  • NEA 0.20
  • MACD
  • NUWE 0.01
  • NEA -0.01
  • Stochastic Oscillator
  • NUWE 64.29
  • NEA 55.56

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: